INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 45m ago
HOUSE PTR5m ago
SEC 13F5m ago
ROBINHOOD CHAIN4m ago
HJ
Corporate insider

Hoitt Jason

Chief Patient OfficerCIK 0001762572

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score40
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
40
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$25K
748 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Stoke Therapeutics, Inc.Chief Patient Officer · Mar 19, 2026
32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL
$4,419
139 sh
Mar 18, 2026
Mar 19, 2026
traded Mar 18, 2026
+1d
SEC FORM 4

Evidence

32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$986
30 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

40
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$34K
1,033 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

39
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$55K
1,762 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence